Patient preference in choosing biological therapy in Crohn's disease

Inflamm Bowel Dis. 2011 Jul;17(7):E79. doi: 10.1002/ibd.21767. Epub 2011 May 1.

Authors

S T C Peake, J Landy, M Hussein, C T Tee, M O'Connor, T Tyrrell, A Akbar, A L Hart

PMID: 21538722
DOI: 10.1002/ibd.21767

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Crohn Disease / drug therapy*
Humans
Patient Preference*

Substances

Antineoplastic Agents